固体无形配方可增强溶解性和抑制Erlotinib在胃肠转移期间的结晶
L Mugnier1, F Espitalier1, J Menegotto2
1Université de Toulouse, IMT Mines Albi, UMR CNRS 5302, Centre RAPSODEE, Albi, France.
Pharmaceutical development and technology
|July 11, 2023
概括
这项研究开发了无形固体分散剂,以改善埃洛提尼布 (ERL) 溶解度并防止结晶. 使用HPMC-AS-L的冷磨砂挤出物显示出口服药物输送的最佳性能.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
背景情况:
- 埃尔洛丁尼布 (ERL) 是一种激酶抑制剂,是生物制药分类系统II类药物,溶性差.
- 在胃肠道过境期间的结晶可以降低口服生物可用性,如ERL.可溶性较差的药物.
研究的目的:
- 为了增强Erlotinib的溶解性并抑制其在胃肠传输过程中的结晶.
- 使用各种聚合物和制造技术,开发Erlotinib的稳定无形固体分散 (ASD).
主要方法:
- 基于可溶性和结晶抑制的聚合物的选.
- 使用Soluplus®,HPMC-AS-L和HPMC-AS-H通过喷雾干燥和热挤出来制备ERL ASD.
- 关于ASD的特征,包括热性质,粒子大小,可溶性和溶解行为.
主要成果:
- 使用喷雾干燥和热挤出成功制备了无形固体分散物.
- 压磨过的HPMC-AS-L挤出物表现出卓越的性能.
- 在HPMC-AS-L配方中观察到提高溶解度和减少RL结晶.
结论:
- 冷磨 HPMC-AS-L 挤出物代表了埃尔洛丁尼布的一个有前途的无形固体分散配方.
- 制造过程显著影响RL ASDs的坚固特性和性能.
- 这种方法为改善BCSII类药物的口服输送提供了可行的策略.
相关概念视频
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
231
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
231
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
342
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
342
Factors Influencing Drug Absorption: Physicochemical Parameters
326
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
326
Factors Influencing Drug Absorption: Drug Dissolution
584
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
584
Factors Influencing Drug Absorption: Pharmaceutical Parameters
155
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
155
Routes of Drug Administration: Enteral
3.8K
Medications can be administered through the enteral route using liquids, capsules, or tablets.
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
3.8K


